Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
120 hedge funds and large institutions have $776M invested in Intersect ENT, Inc in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 12 closing their positions.
654% more call options, than puts
Call options by funds: $22.3M | Put options by funds: $2.95M
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
49% more capital invested
Capital invested by funds: $521M → $776M (+$255M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
7% more funds holding
Funds holding: 112 → 120 (+8)
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
+$7.4M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$5.46M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$5.07M |
| 4 |
Jennison Associates
New York
|
+$4.72M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.23M |
| 2 |
Man Group
London,
United Kingdom
|
-$7.59M |
| 3 |
DM
Deerfield Management
New York
|
-$6.32M |
| 4 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
-$4.87M |
| 5 |
Morgan Stanley
New York
|
-$4.66M |
XENT Hedge Fund Activity: Q4 2019 in Review
120 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2019, worth a combined $776M — up 49% from $521M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new XENT positions and 12 closed out — a net gain of 10 holders — while 42 added to existing stakes and 40 trimmed.
The largest buyer was Polar Capital, opening a new position worth an estimated $7.4M. The largest seller was Point72 Asset Management, cutting an estimated $9.23M.
- 120 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2019, up from 112 in Q3 2019.
- Funds reported $776M of Intersect ENT, Inc stock for Q4 2019, up 49% quarter-over-quarter.
- 22 funds opened new Intersect ENT, Inc positions in Q4 2019 and 12 closed out, a net change of +10 holders.
- The largest Intersect ENT, Inc buyer in Q4 2019 was Polar Capital, an estimated $7.4M added.
- The largest Intersect ENT, Inc seller in Q4 2019 was Point72 Asset Management, an estimated $9.23M sold.
Based on aggregated 13F filings for Q4 2019.